While digital adoption in the pharma industry is inevitable and COVID-19 has only crunched the timeline, the future lies in "panomics" – a term that encompasses genomics, transcriptomics, proteomics and metabolomics – and precision medicine, Moderna, Inc.’s chief commercial officer Corinne Le Goff said at a recent event.
In a keynote address at the Indegene Digital Summit on the new paradigm for a post-pandemic world, Le Goff mentioned that COVID-19 had changed “everything”
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?